CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3036% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx total assets
Total assets on the balance sheet at the end of each period.
CareDx's total assets was $641.46M at Sep 30, 2026. For fiscal 2025 it was $413.23M, down 15.8% from the year before. Over ten years it grew 22.2% a year on average. The highest annual figure on record is $566.62M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $413.23M | -15.8% |
| FY2024 | Dec 31, 2024 | $491.05M | +5.2% |
| FY2023 | Dec 31, 2023 | $466.83M | -14.0% |
| FY2022 | Dec 31, 2022 | $542.99M | -4.2% |
| FY2021 | Dec 31, 2021 | $566.62M | +53.8% |
| FY2020 | Dec 31, 2020 | $368.51M | +142.9% |
| FY2019 | Dec 31, 2019 | $151.74M | +16.1% |
| FY2018 | Dec 31, 2018 | $130.70M | +56.4% |
| FY2017 | Dec 31, 2017 | $83.57M | +8.9% |
| FY2016 | Dec 31, 2016 | $76.73M | +37.9% |
| FY2015 | Dec 31, 2015 | $55.64M | -9.0% |
| FY2014 | Dec 31, 2014 | $61.14M | +519.3% |
| FY2013 | Dec 31, 2013 | $9.87M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $641.46M | +48.4% |
| Q2 FY2026 | Jun 30, 2026 | $532.99M | +20.0% |
| Q1 FY2026 | Mar 31, 2026 | $411.06M | -16.0% |
| Q4 FY2025 | Dec 31, 2025 | $413.23M | -15.8% |
| Q3 FY2025 | Sep 30, 2025 | $432.31M | -9.4% |
| Q2 FY2025 | Jun 30, 2025 | $444.26M | -4.8% |
| Q1 FY2025 | Mar 31, 2025 | $489.64M | +8.2% |
| Q4 FY2024 | Dec 31, 2024 | $491.05M | +5.2% |
| Q3 FY2024 | Sep 30, 2024 | $476.99M | -4.8% |
| Q2 FY2024 | Jun 30, 2024 | $466.78M | -9.3% |
| Q1 FY2024 | Mar 31, 2024 | $452.41M | -14.4% |
| Q4 FY2023 | Dec 31, 2023 | $466.83M | -14.0% |
| Q3 FY2023 | Sep 30, 2023 | $501.18M | -8.0% |
| Q2 FY2023 | Jun 30, 2023 | $514.82M | -4.9% |
| Q1 FY2023 | Mar 31, 2023 | $528.22M | -3.4% |
| Q4 FY2022 | Dec 31, 2022 | $542.99M | -4.2% |
| Q3 FY2022 | Sep 30, 2022 | $544.51M | -3.3% |
| Q2 FY2022 | Jun 30, 2022 | $541.29M | -2.9% |
| Q1 FY2022 | Mar 31, 2022 | $546.71M | +1.0% |
| Q4 FY2021 | Dec 31, 2021 | $566.62M | +53.8% |
| Q3 FY2021 | Sep 30, 2021 | $563.17M | +59.3% |
| Q2 FY2021 | Jun 30, 2021 | $557.42M | +61.7% |
| Q1 FY2021 | Mar 31, 2021 | $541.22M | +245.2% |
| Q4 FY2020 | Dec 31, 2020 | $368.51M | +142.9% |
| Q3 FY2020 | Sep 30, 2020 | $353.55M | +144.1% |
| Q2 FY2020 | Jun 30, 2020 | $344.74M | +141.2% |
| Q1 FY2020 | Mar 31, 2020 | $156.78M | +22.6% |
| Q4 FY2019 | Dec 31, 2019 | $151.74M | +16.1% |
| Q3 FY2019 | Sep 30, 2019 | $144.83M | +58.4% |
| Q2 FY2019 | Jun 30, 2019 | $142.91M | +78.9% |
| Q1 FY2019 | Mar 31, 2019 | $127.86M | +61.9% |
| Q4 FY2018 | Dec 31, 2018 | $130.70M | +56.4% |
| Q3 FY2018 | Sep 30, 2018 | $91.45M | +21.8% |
| Q2 FY2018 | Jun 30, 2018 | $79.88M | +2.8% |
| Q1 FY2018 | Mar 31, 2018 | $78.95M | -1.7% |
| Q4 FY2017 | Dec 31, 2017 | $83.57M | +8.9% |
| Q3 FY2017 | Sep 30, 2017 | $75.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $77.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $80.32M | – |
| Q4 FY2016 | Dec 31, 2016 | $76.73M | – |
See a number that looks wrong?